Discover our latest insights. 

Private Health Management (PHM), a clinically sophisticated healthcare navigation firm specializing in providing the best care and outcomes to individuals facing serious and complex conditions, today announced it has appointed Ken Tarkoff …

PHM introduces ClearCancerIQ (CCIQ), the first-of-its-kind predictive analytics tool designed to help employers size their company’s cancer risk through quantitative analysis of their health plan population. An innovation in PHM’s ClearCancer™ suite of solutions, CCIQ enables companies to develop high impact strategies to manage cancer at both the employee and workforce level.

PHM believes in the importance of having access to cutting-edge cancer diagnostics and therapeutics, and we are excited to announce our peer-reviewed case report in Frontiers in Oncology demonstrating why. This report summarizes the case of a 73 year-old male who went from stage 4B prostate cancer to disease free.

Our client first came to PHM after a year of his diagnosis and there were early signs that standard treatments were not going to adequately control his disease. We connected him to a clinic in Germany using theranostics, a treatment for prostate cancer that was not yet approved in the U.S. He remains disease free five years later.

In the 2023 "Managing Cancer Care in Your Health Plan" whitepaper, PHM brings clinical insights to Springbuk's claims data from more than 1,000 select employers consisting of 1.7 million lives covered. The paper identifies three areas of opportunities for companies to:

1. Encourage prevention through advanced screenings to achieve better health outcomes at lower treatment costs.
2. Enable molecular profiling, still highly underutilized, to ensure cancers are appropriately characterized and individuals are benefiting from the latest in precision medicine.
3. Optimize drug spend by making informed formulary decisions, not merely restricting use of high-cost drugs.

PHM are experts in helping patients overcome barriers to clinical trial access and enrollment, and we applaud the recent draft guidance released by the U.S. Food and Drug Administration (FDA) to make clinical trials …

PHM is proud to be shortlisted for prestigious Family Wealth Report Awards 2020 – Health care Services.